How does PNC-27 work?
Membranolytic peptide. Selectively binds HDM-2 (an oncoprotein) found on the membrane surface of cancer cells (rarely on healthy cells), then lyses the cell membrane. Pre-clinical anti-cancer mechanism. In plain terms, PNC-27 is membranolytic peptide that selectively kills cancer cells expressing HDM-2 (oncoprotein) on the membrane surface. Pre-clinical anti-cancer research compound. Mechanistic detail like this comes largely from preclinical and early research, the human picture is limited.
What people use it for
- Cancer-research contexts under medical oversight
- Educational reference, pre-clinical only
- Compassionate-use research scenarios
References
- PNC-27, anticancer peptide that selectively kills HDM-2-expressing cancer cells — Michl J et al., Anticancer Res, 2006
- Anti-Cancer Peptide PNC-27 Kills Cancer Cells by Unique Interactions with Plasma Membrane-Bound hdm-2 and with Mitochondrial Membranes Causing Mitochondrial Disruption — Krzesaj P et al., Annals of Clinical and Laboratory Science, 2024
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on PNC-27
Last updated 2026-06-06.